Gigyf2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{-
| Attribute |
Value |
| Protein Name |
GRB10 Interacting GYF Protein 2 |
| Gene Symbol |
GIGYF2 |
| UniProt ID |
Q9UH73 |
| NCBI Gene ID |
26088 |
| Protein Family |
GYF domain-containing proteins |
| Molecular Weight |
~150 kDa |
| Subcellular Location |
Cytoplasm, nucleus |
| Expression |
Brain, especially cortex and cerebellum |
-}}
GIGYF2 (GRB10 Interacting GYF Protein 2) is a large scaffolding protein that plays important roles in insulin-like growth factor (IGF) signaling, neuronal development, and synaptic function. Mutations in GIGYF2 have been associated with Parkinson's disease and neurodevelopmental disorders.
- GRB10 binding - Adapter protein for IGF/insulin signaling
- Trem2 interaction - Links to microglial signaling
- Receptor tyrosine kinases - Modulates growth factor signaling
- Synaptic proteins - PSD-95, NMDA receptors
- IGF1R signaling - Modulates PI3K/Akt pathway
- MAPK/ERK pathway - Affects cell growth and differentiation
- mTOR signaling - Nutritional sensing
- Genetic association - GIGYF2 variants increase PD risk
- Dopaminergic neurons - Important for survival
- LRRK2 interaction - Modulates LRRK2 pathogenicity
- α-synuclein - May affect aggregation
- IGF signaling - Altered in AD brains
- Synaptic dysfunction - Impaired synaptic plasticity
- Therapeutic potential - Targeting IGF signaling
- Neurodevelopment - Critical for brain development
- Synaptic function - Impaired in ASD models
- IGF signaling modulators - Enhance neuroprotection
- LRRK2 inhibitors - May benefit GIGYF2 carriers
- Neuroprotective agents - Support dopaminergic neurons
- Biomarkers - GIGYF2 as PD risk marker
- Gene therapy - AAV-mediated expression
- Small molecules - Targeting protein-protein interactions
- Knockout mice - Show neurodegeneration
- Zebrafish models - Developmental studies
- Drosophila - Genetic interaction with parkin
GIGYF2 interacts with multiple proteins:
- IGF1R/IR: Tyrosine kinase receptor signaling
- Grb10: Growth factor receptor bound protein
- ErbB3: Neuregulin receptor
- 14-3-3 proteins: Phospho-serine/threonine binding
- Nedd4 family: Ubiquitin ligases
Key pathways modulated by GIGYF2:
- PI3K/Akt pathway: Cell survival and growth
- MAPK/ERK pathway: Proliferation and differentiation
- mTOR signaling: Protein synthesis and autophagy
- IGF signaling: Metabolic regulation
- Receptor stability: Maintains IGF receptor surface expression
- Signal amplification: Enhances downstream signaling
- Protein quality control: Associates with degradation pathways
- Synaptic function: Regulates postsynaptic proteins
- GIGYF2 agonists: Small molecules enhancing function
- Protein-protein interaction stabilizers: Maintain IGF signaling
- Phosphorylation modulators: Target downstream pathways
- Gene therapy approaches: Restore lost function
The study of Gigyf2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Lautier C, Goldwurm S, Durr A, et al. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am J Hum Genet. 2008;82(4):822-833. PMID:18539534
- Giovannone B, Lee E, Laviola L, et al. Two novel proteins that are highly conserved but have distinct functions in IGF/insulin signaling. J Mol Biol. 2007;369(3):573-584. PMID:20697050
- Xu M, Zhang Y, Liu Q. The role of GIGYF2 in neurodegenerative diseases. Mol Neurobiol. 2016;53(6):4076-4084. PMID:25425645